References
- Pan American Health Organization (PAHO)/World Health Organization (WHO) [Internet]. Chikungunya [cited 2018 Dec 16]. https://www.paho.org/hq/index.php?option=com_topics&view=article&id=343&Itemid=40931&lang=pt
- Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952–1953. I Clinical Features, Transactions of the Royal Society of Tropical Medicine and Hygiene. 1955;49(1):28–32.
- Castro APCR, Lima RA, Nascimento JS. Chikungunya: a visão do clínico de dor [Chikungunya: the clinical view of the pain]. Revista Dor. 2016;17(4):299–302.
- Pialoux G, Gaüzère BA, Jauréguiberry S, et al. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis. 2007;7(5):319–327.
- Brito CAA. Alert: severe cases and deaths associated with Chikungunya in Brazil. Rev Soc Bras Med Trop. 2017;50(5):585–589.
- Pan American Health Organization (PAHO)/World Health Organization (WHO). [Internet]. Novos casos de Chikungunya nas Américas 2013–2017, por ano e por país [New Cases of Chikungunya at America 2013-2017, by year and country]. [cited 2018 Dec 18]. http://ais.paho.org/phip/viz/ed_chikungunya_amro.asp.
- Diallo M, Thonnon J, Traore-Lamizana M, et al. Vectors of Chikungunya virus in Senegal: current data and transmission cycles. Am J Trop Med Hyg. 1999;60(2):281–286.
- Pulmanausahakul R, Roytrakul S, Auewarakul P, et al. Chikungunya in Southeast Asia: understanding the emergence and finding solutions. Inter J Infect Dis. 2011;15(10):671–676.
- Brasil. Monitoramento dos casos de dengue, febre de chikungunya e doença aguda pelo vírus Zika até a Semana Epidemiológica 49 de 2018 [Monitoring of cases of dengue fever, chikungunya fever and Zika vírus fever up to 49th epidemiological week 49, 2018]. Ministerio da Saúde. Brasilia. 2018;49(59):1–14.
- Harapan H, Michie A, Mudatsir M, et al. Chikungunya virus infection in Indonesia: a systematic review and evolutionary analysis. BMC Infect Dis. 2019;19(243):1–20.
- Rezza G, Nicoletti L, Angelini R, et al. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet. 2007;370(9602):1840–1846.
- Rezza G. Chikungunya is back in Italy: 2007–2017. J Travel Med. 2018;25(1):1–4.
- Weaver SC. Arrival of Chikungunya virus in the new world: prospects for spread and impact on public health. PLoS Negl Trop Dis. 2014;8(6):e2921–e2924.
- Venturi G, Luca MD, Fortuna C, et al. Detection of a chikungunya outbreak in Central Italy, august to september 2017. Eurosurveillance. 2017;22(39)17–00646.
- Wimalasiri-Yapa BMCR, Stassen L, Huang X, et al. Chikungunya virus in Asia - Pacific: a systematic review. Emerg Microbes Infect. 2019;8(1):70–79.
- Muniz Júnior RL, Godói IP, Reis EA, et al. Consumer willingness to pay for a hypothetical Zika vaccine in Brazil and the implications. In Expert review of pharmacoeconomics & outcomes research. 2019;19(4):473–482.
- Godoi IP, Da Silva LVD, Sarker AR, et al. Economic and epidemiological impact of dengue illness over 16 years from a public health system perspective in Brazil to inform future health policies including the adoption of a dengue vaccine. Expert Rev Vaccines. 2018;17(12):1123–1133.
- Chang LJ, Dowd KA, Mendoza FH, et al. Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial. Lancet. 2014;384(9959):2046–2052.
- ClinicalTrials.gov. National Library of Medicine (US) [Internet]. Identifier NCT02861586; NCT01489358. Completed studies for chikungunya vaccines. [cited 2019 Jan 21]; About 9 screens. https://clinicaltrials.gov/ct2/results?cond=chikungunya&Search=Apply&recrs=e&age_v=&gndr=&type=&rslt=.
- Brasil. Agência Nacional de Vigilância Sanitária [Sanitary Surveillance National Agency]. Resolução CMED n◦ 2, de 05 de Março de 2004 [Resolution number 2, May 05 2004]. Brasília; 2004.
- Brasil. Decreto n. 12.401, 28 de Abril de 2011. “Da assistência terapêutica e da incorporação de tecnologia em saúde” [Therapeutic assistance and health technology incorporation]; [cited 2019 Jan 21]. http://www.planalto.gov.br/ccivil_03/_Ato2011-2014/2011/Lei/L12401.htm.
- Godoi IP, Santos AS, Reis EA, et al. Consumer willingness to pay for dengue vaccine (CYD-TDV, Dengvaxia®) in Brazil; implications for future pricing considerations. Front Pharmacol. 2017;8(41)1–9.
- Brasil. Vacina contra dengue tem preço definido [Internet] [Dengue vaccine has defined price]; 2016 Jul 25 [cited 2018 Jan 21]. http://portal.anvisa.gov.br/noticias/-/asset_publisher/FXrpx9qY7FbU/content/vacina-contra-dengue-tem-preco-definido/219201.
- Haab T, Mcconnell K. Valuing Environmental and Natural Resources: the economics of non-market vauation. (New horizons in environmental economics). Cheltenham, UK: Edward Elgar Publishing Limited; 2002.
- Harapan H, Fajar JK, Sasmono RT, et al. Dengue vaccine acceptance and willingness to pay. Hum Vaccin Immunother. 2016;13(4):786–790.
- Hadisoemarto PF, Castro MC. Public acceptance and willingness-to-pay for a future dengue vaccine: a community-based survey in bandung, Indonesia. PLoS Negl Trop Dis. 2013;7(9):2427–2439.
- Harapan H, Anwar S, Bustamam A, et al. Willingness to pay for a dengue vaccine and its associated determinants in Indonesia: A community-based, cross-sectional survey in Aceh. Acta Trop. 2017;166:249–256.
- Cameron MP, Newman PA, Roungprakhon S, et al. The marginal willingness-to-pay for attributes of a hypothetical HIV Vaccine. Vaccine. 2013;31(36):3712–3717.
- Udezi W, Usifoh C, Ihimekpen O. Willingness to pay for three hypothetical malaria vaccines in Nigeria. Clin Ther. 2010;32(8):1533–1544.
- Ughasoro MD, Esangbedo DO, Tagbo BN, et al. Acceptability and willingness-to-pay for a hypothetical ebola virus vaccine in Nigeria. PLoS Negl Trop Dis. 2015;9(6):3838–3853.
- Harapan H, Mudatsir M, Yufika A, et al. Community acceptance and willingness-to-pay for a hypothetical Zika vaccine: A cross-sectional study in Indonesia. Vaccine. 2019;37(11):1398–1406.
- MF DRUMMOND. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2015.
- United Nations Office of Drugs and Crime – UNODC. United Nations in Brazil opposes lowering the legal age of majority [Internet]. [cited 2019 May 6]. https://www.unodc.org/lpo-brazil/en/frontpage/2015/05/11-united-nations-in-brazil-opposes-lowering-the-legal-age-of-majority.html
- Instituto Brasileiro de Geografia e Estatística – IBGE (Brazilian Institute of Geographics and Statistics). Minas Gerais [internet]. [cited 2019 Apr 4]. https://cidades.ibge.gov.br/brasil/mg/panorama.
- Atlas do Desenvolvimento Humano no Brasil (2016). Indicadores no Brasil [Internet]. [cited 2018 Nov 07] http://www.atlasbrasil.org.br/2013/.
- Palanca-Tan R. The demand for a dengue vaccine: a contingent valuation. Survey in Metro Manila. Vaccine. 2018;26(7):914–923.
- Bekker-Grob EW, Ryan M, Gerard K. Discrete choice experiments in health economics: a review of the literature. Health Econ. 2010;21(2):145–172.
- Ryan M, Gerard K. Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy. 2003;2(1):55–64.
- Lee JS, Mogasale V, Lim JK, et al. A multi-country study of the household willingness-to-pay for dengue vaccines: household surveys in Vietnam, Thailand, and Colombia. PLoS Negl Trop Dis. 2015;9(6):3810–3825.
- Chien YL, Huang CJ, Shaw D. A general model of starting point bias in double-bounded dichotomous contingent valuation surveys. J Environ Econ Manage. 2004;50(2):362–377.
- Furnham A, Boo HC. A literature review of the anchoring effect. J Socio Econ. 2011;40(1):35–42.
- World Health Organization (WHO). April 2008. Brazil’s health system reaches out to the poor [internet]. [cited 2018 Jan 21]. Available from: http://www.who.int/bulletin/volumes/86/4/08-030408/en
- Brasil. Lista Nacional de Notificação Compulsória de doenças, agravos e eventos de saúde. Portaria Nº 204, De 17 De Fevereiro De 2016 [National List of Compulsory Notification of diseases, injuries and health events. Ordinance No. 204, of February 17, 2016]. Brasília, 2016.
- Valor. Finanças: À espera do 1º turno, dólar pega carona no exterior e cai para R$ 3,85 [influenced by the exterior, dolar drops to 3.85 BRL]. [cited 2018 Nov 07]. https://www.valor.com.br/financas/5907765/espera-do-1-turno-dolar-pega-carona-no-exterior-e-cai-para-r-385.
- Javan JN, Kavosi Z, Faramarzi A, et al. Identification determinant factors on willingness to pay for health services in Iran. Health Econ Rev. 2017;7(1)1–6.
- Kim SY, Sagiraju HK, Russell LB, et al. Willingness-to-pay for vaccines in low- and middle-income countries: a systematic review. Ann Vaccines Immunization. 2014;1(1):1001.
- Godoi IP, Lemos LL, de Araujo VE, et al. CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety. J Comp Eff Res. 2017;6(2):165–180.
- World Bank Group. PIB per capita (US$ a precios actuales) [internet]. [cited 2018 Nov 16]. https://data.worldbank.org/indicator/ny.gdp.pcap.cd.
- Smith J, Noble H. Bias in research. Evidence Based Nurs. 2014;17(4):100–101.
- Pannucci CJ, Wilkins EG. Identifying and avoiding bias in research. Plast Reconstr Surg. 2010;126(2):619–625.
- Kimenju SC, Morawetz UB, De Groote H. Comparing contingent valuation method, choice experiments and experimental auctions in soliciting consumer preference for maize in Western Kenya: preliminary results. Agric Econ. 2005;42(1):1–16.